ClinicalTrials.gg
Not yet recruitingNCT07925710Updated Nov 9, 2026

Osteoarthritis Care Tools for Primary Care Providers in Family Medicine and Geriatrics Clinics

An interventional study of OACareTools+ in Arthritis and Osteo Arthritis Knee and Hip, sponsored by University of North Carolina, Chapel Hill. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Health services research

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
205
Allocation
Non-randomized
Ages
18 Years to 99 Years
Sex
All
01

Study summary

The purpose of this study is to test the implementation of OACareTools+, a program designed to help healthcare providers connect adults with arthritis to physical activity programs. OACareTools+ includes provider training, patient resources, and tools to make referrals easier. The goal is to increase awareness of programs like Walk With Ease and help more people with arthritis participate in them.

Read the detailed description

Participants will be clinicians (n= 165) in geriatrics and family medicine clinics and a subset of patients (n=30). The study team will deliver education and resources to providers in a training session about Walk With Ease. After the provider training, providers will use the study resources to refer patients with arthritis to Walk With Ease. Healthcare provider participants will complete surveys after their first referral and at the end of the study (12-months). Patient participants who are referred to Walk With Ease through the OACareTools+ intervention will be invited to participate in interviews about their experience (6-weeks) with the referral process. Primary endpoints of the study will be 1) number of healthcare providers that referred patients to Walk With Ease 2) number of Walk With Ease patient participants 3) healthcare provider acceptability and feasibility 4) patient acceptability of the intervention.

02

Conditions studied

  • Arthritis
  • Osteo Arthritis Knee and Hip

Browse trials for

Keywords

  • healthcare providers
  • arthritis
  • primary care
03

In context

Arthritis

843 studies on the registry are indexed under Arthritis; 118 are open to participants now.

This study's planned enrollment of 205 is above the median of 97 across 599 interventional studies indexed under Arthritis.

Browse Arthritis studies →

Lead sponsor

University of North Carolina, Chapel Hill is the lead sponsor of 1,372 studies on the registry; 133 are open to participants now.

Of its 161 completed or terminated interventional studies of FDA-regulated products, 139 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthcare provider participants: currently a healthcare provider or staff person in the UNC study clinics (Geriatrics and Family Medicine)
  • Patient participants: 18 years or older; received a referral to Walk With Ease from a provider at a UNC study clinic or used clinic flyers to register for Walk with Ease and agreed to participate in the phone interview on the post-Walk With Ease evaluation form

Exclusion criteria

Exclusion Criteria:

  • Both: non-English speaking
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
205 participants (estimated)

Study arms

  • Experimental
    Healthcare providers

    Healthcare providers will receive the intervention, OACareTools+, which involves a training session on, patient resources about, and provider referral to Walk With Ease.

    Behavioral: OACareTools+

  • Experimental
    Patients

    A subset of patients who are referred through OACareTools+ to Walk With Ease will provide feedback on their experience with the referral process to Walk With Ease.

    Behavioral: OACareTools+

Interventions

  • BehavioralOACareTools+

    OACareTools+ is a healthcare provider intervention that combines healthcare provider education, customized patient and clinical resources, and technical support from a national organization to facilitate provider counseling on and referral to as well as patient engagement in Walk With Ease. There are 2 main parts to this intervention: 1) Healthcare provider education: The study team will deliver the provider education and resources (including information about Walk With Ease and the established referral process/smartphrase) in live and recorded presentations and in follow-up emails. 2) Implementation: Providers will use the resources to briefly counsel patients about physical activity and Walk With Ease and use the smartphrase to refer patients to Walk With Ease. Patients will register for and participate in the online Walk With Ease program. Patients and providers can seek assistance from the national organization as needed during these processes.

    Also known as: Walk with Ease, Camine con Gusto

06

What researchers measure

Primary outcomes

  1. Number of healthcare providers who referred patients

    Healthcare providers in the study clinics who refer patients to the Walk With Ease program using the study referral process and resources

    Time frame: 12 months

  2. Number of patients who registered for Walk with Ease

    Patients from the study clinics who register in the Walk With Ease program

    Time frame: 12 months

  3. Healthcare provider acceptability

    The Acceptability of Intervention Measure is a measure of implementation outcomes, including 4 items ranked on a Likert scale of 1 (completely disagree) to 5 (completely agree), with a summed total ranging from 4-20 where higher scores indicate greater acceptability; measured via electronic survey.

    Time frame: Measure collected up to 2 months after provider's first referral

  4. Healthcare provider feasibility

    The Feasibility of Intervention Measure is a measure of implementation outcomes, including 4 items ranked on a Likert scale of 1 (completely disagree) to 5 (completely agree), with a summed total ranging from 4-20 where higher scores indicate greater feasibility; measured via electronic survey.

    Time frame: Measure collected up to 2 months after provider's first referral

  5. Patient usefulness: educational resources

    During a phone interview, patients will be asked, "How helpful were the education materials given to you by your healthcare provider?" They will be asked to use a scale, 0-10, where 0 is not helpful at all and 10 is extremely helpful. Higher scores indicate greater levels of helpfulness.

    Time frame: 6-weeks post-Walk with Ease registration

  6. Patient usefulness: clinician referral to Walk With Ease

    During a phone interview, patients will be asked, "How helpful was it to talk with healthcare provider about physical activity and Walk With Ease?" They will be asked to use a scale, 0-10, where 0 is not helpful at all and 10 is extremely helpful. Higher scores indicate greater levels of helpfulness.

    Time frame: 6-weeks post- Walk With Ease registration

  7. Patient acceptability

    The Acceptability of Intervention Measure is a measure of implementation outcomes, including 4 items ranked on a Likert scale of 1 (completely disagree) to 5 (completely agree), with a summed total ranging from 4-20 where higher scores indicate greater acceptability; measured via telephone interview.

    Time frame: 6-weeks post- Walk With Ease registration

07

Study locations

1 site
  • UNC Thurston Arthritis Research Center
    Chapel Hill, North Carolina 27599, United States
08

References and documents

Individual participant data

Plan to share: Yes — Deidentified individual data that support the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC. Data collected include: pre/post walking program assessments, referral count, patient engagement metrics, arthritis outcomes, satisfaction (provider and patient). Qualitative data will be available in the form of a summary.

Supporting information: Study protocol, Informed consent form

Time frame: Beginning 9 and continuing for 36 months following publication.

Access criteria: Approved IRB, IEC, or REB and an executed data use/sharing agreement with UNC.

Data sharing details ↗ · dataverse.unc.edu

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07925710
Responsible party
Sponsor
First posted
Nov 9, 2026
Start date
Nov 13, 2026 (estimated)
Primary completion
Nov 12, 2027 (estimated)
Completion
Nov 12, 2027 (estimated)
Last update
Nov 9, 2026

Study contacts

Katie Huffman
Contact
katie_huffman@med.unc.edu
919-962-5145
Leigh Callahan, PhD
principal investigator · UNC Thurston Arthritis Research Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion